Related Experiment Video
Updated: Jun 13, 2026
12:46
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
Interleukin 6 activity associated with a cardiac lymphoma
Mario Chiavarelli1, Emma Borrelli, Fabrizio Gandolfo
1Division of Cardiac Surgery, University Hospital Le Scotte, Viale Bracci, Siena, Italy. chiavarelli@unisi.it
The Heart Surgery Forum
|May 7, 2010
Summary
Primary cardiac B-cell lymphoma is a rare heart tumor. High levels of interleukin 6 may correlate with symptoms, decreasing after tumor removal.
Area of Science:
- Cardiology
- Oncology
- Immunology
Background:
- Primary cardiac B-cell lymphoma is an extremely rare cardiac tumor.
- Diagnosis can be challenging due to nonspecific clinical signs.
- Cardiac myxomas and mediastinal lymphomas are known to elevate serum cytokines.
Observation:
- A case of intracardiac large B-cell lymphoma in a 75-year-old female patient is presented.
- The patient exhibited elevated serum levels of interleukin 6 (IL-6).
- IL-6 levels decreased significantly following surgical tumor excision.
Findings:
- The study suggests a potential correlation between cardiac B-cell lymphoma and interleukin 6 overproduction.
- Elevated IL-6 levels may be linked to the clinical manifestations of cardiac B-cell lymphoma.
Implications:
- This finding could offer a potential biomarker for diagnosing and monitoring cardiac B-cell lymphoma.
- Further research into the role of IL-6 in cardiac lymphomas is warranted.
- Understanding cytokine involvement may improve patient outcomes for rare cardiac tumors.
